<?xml version="1.0" encoding="UTF-8"?>
<ref id="B110-antioxidants-09-01191">
 <label>110.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Luo</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Sun</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Dong</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Qin</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Yu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Sun</surname>
    <given-names>X.</given-names>
   </name>
  </person-group>
  <article-title>Isorhamnetin attenuates atherosclerosis by inhibiting macrophage apoptosis via PI3K/AKT activation and HO-1 induction</article-title>
  <source>PLoS ONE</source>
  <year>2015</year>
  <volume>10</volume>
  <fpage>e0120259</fpage>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0120259</pub-id>
  <pub-id pub-id-type="pmid">25799286</pub-id>
 </element-citation>
</ref>
